BR112012004988A2 - compostos para tratar transtornos ou doenças associadas com atividade do receptor de neuroquinina 2 - Google Patents
compostos para tratar transtornos ou doenças associadas com atividade do receptor de neuroquinina 2Info
- Publication number
- BR112012004988A2 BR112012004988A2 BR112012004988A BR112012004988A BR112012004988A2 BR 112012004988 A2 BR112012004988 A2 BR 112012004988A2 BR 112012004988 A BR112012004988 A BR 112012004988A BR 112012004988 A BR112012004988 A BR 112012004988A BR 112012004988 A2 BR112012004988 A2 BR 112012004988A2
- Authority
- BR
- Brazil
- Prior art keywords
- neurokinin
- compounds
- diseases associated
- receptor activity
- treating disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/003—Esters of saturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24001409P | 2009-09-04 | 2009-09-04 | |
PCT/US2010/048006 WO2011029099A1 (en) | 2009-09-04 | 2010-09-07 | Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012004988A2 true BR112012004988A2 (pt) | 2015-09-08 |
Family
ID=43649685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012004988A BR112012004988A2 (pt) | 2009-09-04 | 2010-09-07 | compostos para tratar transtornos ou doenças associadas com atividade do receptor de neuroquinina 2 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20120190743A1 (pt) |
EP (1) | EP2473038A4 (pt) |
JP (1) | JP2013503908A (pt) |
KR (1) | KR20120081120A (pt) |
CN (1) | CN102740693A (pt) |
AU (1) | AU2010289276A1 (pt) |
BR (1) | BR112012004988A2 (pt) |
CA (1) | CA2773035A1 (pt) |
MX (1) | MX2012002551A (pt) |
NZ (1) | NZ599215A (pt) |
RU (1) | RU2012112943A (pt) |
SG (1) | SG178964A1 (pt) |
WO (1) | WO2011029099A1 (pt) |
ZA (1) | ZA201202492B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2508180A1 (en) * | 2011-04-04 | 2012-10-10 | Nestec S.A. | Sn-1(3) Monoacylglycerides and lipid absorption |
EP3027199B1 (en) | 2013-08-01 | 2019-06-26 | Dignify Therapeutics, LLC | Compositions and methods for inducing urinary voiding and defecation |
GB201315846D0 (en) | 2013-09-05 | 2013-10-23 | Imp Innovations Ltd | Method for treating or preventing hot flushes |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1001A (en) * | 1838-11-09 | Open grate fobj burning coai | ||
GB820954A (en) * | 1956-05-02 | 1959-09-30 | Beecham Res Lab | Improvements in or relating to esters of 2,3-dimercaptopropanol |
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
JPS505309A (pt) * | 1973-05-28 | 1975-01-21 | ||
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
JPH02131418A (ja) * | 1988-11-10 | 1990-05-21 | Sansho Seiyaku Co Ltd | 外用剤 |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
DE4204151A1 (de) * | 1992-02-12 | 1993-08-19 | Schneider Manfred Prof Dr | Regioisomerenreine monoglyceride sowie ein verfahren zu ihrer herstellung durch enzymatische veresterung von glycerin in organischen loesungsmitteln |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
JPH0931020A (ja) * | 1995-07-25 | 1997-02-04 | Soda Koryo Kk | グリセロールモノ−6−ヒドロキシアルカン酸エステル、及びこれを含有する香料組成物 |
SE9604582D0 (sv) * | 1996-12-13 | 1996-12-13 | Astra Ab | Novel compounds |
DE60020987T2 (de) * | 1999-11-18 | 2006-05-11 | Pederson, Richard L., San Gabriel | Methathesesynthese von pheromonen oder ihrer bestandteile |
MY141736A (en) * | 2002-10-08 | 2010-06-15 | Elanco Animal Health Ireland | Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists |
JO2676B1 (en) * | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
CN1286529C (zh) * | 2004-06-11 | 2006-11-29 | 华中科技大学 | 具有皮肤靶向性的药物组合物及其制备方法和用途 |
US7906147B2 (en) * | 2006-10-12 | 2011-03-15 | Nanoprobes, Inc. | Functional associative coatings for nanoparticles |
CN101969965A (zh) | 2008-01-11 | 2011-02-09 | 统一帕拉贡联合有限公司 | 受精卵分离物及其用途 |
-
2010
- 2010-09-07 SG SG2012015046A patent/SG178964A1/en unknown
- 2010-09-07 RU RU2012112943/04A patent/RU2012112943A/ru not_active Application Discontinuation
- 2010-09-07 WO PCT/US2010/048006 patent/WO2011029099A1/en active Application Filing
- 2010-09-07 CN CN2010800501768A patent/CN102740693A/zh active Pending
- 2010-09-07 AU AU2010289276A patent/AU2010289276A1/en not_active Abandoned
- 2010-09-07 EP EP10814632.5A patent/EP2473038A4/en not_active Withdrawn
- 2010-09-07 JP JP2012528118A patent/JP2013503908A/ja active Pending
- 2010-09-07 US US13/394,067 patent/US20120190743A1/en not_active Abandoned
- 2010-09-07 KR KR1020127008768A patent/KR20120081120A/ko not_active Application Discontinuation
- 2010-09-07 NZ NZ599215A patent/NZ599215A/en not_active IP Right Cessation
- 2010-09-07 BR BR112012004988A patent/BR112012004988A2/pt not_active Application Discontinuation
- 2010-09-07 CA CA2773035A patent/CA2773035A1/en not_active Abandoned
- 2010-09-07 MX MX2012002551A patent/MX2012002551A/es not_active Application Discontinuation
-
2012
- 2012-04-04 ZA ZA2012/02492A patent/ZA201202492B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ599215A (en) | 2014-11-28 |
JP2013503908A (ja) | 2013-02-04 |
CN102740693A (zh) | 2012-10-17 |
US20120190743A1 (en) | 2012-07-26 |
ZA201202492B (en) | 2013-02-27 |
RU2012112943A (ru) | 2013-10-10 |
KR20120081120A (ko) | 2012-07-18 |
AU2010289276A1 (en) | 2012-05-03 |
MX2012002551A (es) | 2012-09-07 |
SG178964A1 (en) | 2012-04-27 |
EP2473038A1 (en) | 2012-07-11 |
CA2773035A1 (en) | 2011-03-10 |
EP2473038A4 (en) | 2013-10-23 |
WO2011029099A1 (en) | 2011-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919920A2 (pt) | compostos para tratamento de doenças e desordens oftálmicas | |
BR112014014276A2 (pt) | composto, composição farmacêutica, método para inibir uma cinase receptora, e, métodos para tratar condições, doenças e/ou distúrbios, e dor | |
BRPI0912362A2 (pt) | antagonista do receptor nmda para o tratamento de transtornos neuropsiquiátricos | |
BRPI0906618A2 (pt) | Derivados de diazepinorimidona de arilamida substituídos para o tratamento de doenças neu-rodegenerativas causadas por atividade anorma de gsk3-beta | |
BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
BR112014026285A2 (pt) | oligonucleotídeos moduladores de rna com características melhoradas para o tratamento de distúrbios neuromusculares | |
BRPI0812755A2 (pt) | Compostos de derivados de fenil alquinila para tratar doenças, e desordens oftálmicas | |
BRPI0918527A2 (pt) | compostos para o tratamento de disturbios do cns | |
BRPI0819241A2 (pt) | Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas | |
CR11019A (es) | 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas | |
BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
BRPI0911577A8 (pt) | derivados espiro-indol para o tratamento de doenças parasíticas. | |
BRPI1009783A2 (pt) | compostos para o tratamento de distúrbios metabólicos. | |
BRPI0822012A2 (pt) | Derivados de quinazolina de 6,7-dialcóxi úteis para o tratamento de distúrbios relacionados com câncer | |
BRPI0816175A2 (pt) | Composições adequadas para tratamento de doença, distúrbio ou condição da espinha. | |
BRPI1014994A2 (pt) | 2,4-diamino pirimidinas para o tratamento de doenças caracterizadas por proliferação excessiva ou anormal de células | |
BR112013031117A2 (pt) | scilo-inositol para o tratamento de transtornos comportamentais e psiquiátricos. | |
BRPI0909628A2 (pt) | compostos de azaindol para o tratamento de distúrbios do sistema nervosos central | |
BRPI1013245A2 (pt) | "composto para o tratamento de distúrbios metabólicos" | |
BRPI0917440A2 (pt) | composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho | |
BRPI0915428A2 (pt) | derivados de benzoxazinona atuando como agonistas adrenorreceptor beta2 para o tratamento de distúrbios respiratórios | |
BRPI1013777A2 (pt) | compostos agonistas do receptor 5-ht4 para tratamento de distúrbios cognitivos. | |
BRPI0906606A2 (pt) | Tratamento terapêutico para condições do pulmão. | |
GB0915259D0 (en) | Sulphur-linked compounds for treating ophthalmic diseases and disorders | |
BR112013017148A2 (pt) | composto, composição farmacêutica, método para tratar uma doença ou distúrbio, método para tratar uma doença mediada por hdac e método para tratar tanto as doenças associadas com hedgehog como as doenças associadas à hdac |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority |
Free format text: PERDA DA PRIORIDADE US 61/240,014 DE 04/09/2009 REIVINDICADA NO PCT/US2010/048006, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O, DECRETO NO. 635 DE 21/08/1992 E CONVENCAO DA UNIAO DE PARIS (REVISTA EM ESTOCOLMO 14/07/1967), ART. 4O, ALINEA C, ITEM 1. ESTA PERDA SE DEU PELO FATO DO BRASIL NAO ACEITAR RESTAURACAO DE PRIORIDADE (RESERVA DO BRASIL DE ACORDO COM A REGRA 49TER.1 ALINEA (G) E 49TER.2 ALINEA (H) DO REGULAMENTO DE EXECUCAO DO PCT), JA QUE O PRAZO PARA O DEPOSITO INTERNACIONAL COM REIVINDICACAO DE PRIORIDADE ULTRAPASSOU OS 12 MESES. |
|
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |